Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

​Join Medicilon at SITC 2023 in San Diego

2023-10-28
|
Page View:

1.png

Ready to Meet Medicilon at SITC's 38th Annual Meeting & Pre-Conference Programs (SITC2023)?

We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities.

Cellular immunotherapy has developed by leaps and bounds in recent years, providing a cure for many difficult-to-treat cancers. Medicilon has built a one-stop service platform for the preclinical R&D of cellular immunotherapies, covering a variety of immunotherapy methods including CAR-T, TCR-T and CAR-NK. Using a wealth of animal models and a variety of advanced analysis techniques, comprehensively considering the characteristics of different research projects, Medicilon has completed numerous pre-clinical projects for clients worldwide (Non-clinical Research for Cellular Immunotherapies

Date: November 11-15, 2023

Location: San Diego Convention Center

Medicilon Booth#1135

About SITC2023

3.pngIf you would like the full agenda, please send an email to marketing@medicilon.com.

Share:
Return
Relevant newsRelevant news